BFS
AZN icon

Bradley Foster & Sargent’s AstraZeneca AZN Stock Holding History

Bradley Foster & Sargent’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Buy
3,851
+231
+6% +$43.4K 0.01% 348
2026
Q1 		$714K Buy
+3,620
New +$698K 0.01% 333
2025
Q4 		– Sell
-3,441
Closed -$528K – 528
2025
Q3 		$528K Sell
3,441
-28
-0.8% -$4.24K 0.01% 384
2025
Q2 		$485K Buy
3,469
+163
+5% +$22.8K 0.01% 389
2025
Q1 		$486K Hold
3,306
– – 0.01% 346
2024
Q4 		$433K Hold
3,306
– – 0.01% 375
2024
Q3 		$515K Hold
3,306
– – 0.01% 355
2024
Q2 		$516K Sell
3,306
-201
-6% -$30.2K 0.01% 350
2024
Q1 		$475K Hold
3,507
– – 0.01% 352
2023
Q4 		$472K Sell
3,507
-18,825
-84% -$2.45M 0.01% 352
2023
Q3 		$3.2M Hold
22,332
– – 0.07% 172
2023
Q2 		$3.2M Buy
22,332
+18,937
+558% +$2.79M 0.07% 172
2023
Q1 		$471K Sell
3,395
-2,251
-40% -$303K 0.01% 335
2022
Q4 		$766K Hold
5,646
– – 0.02% 276
2022
Q3 		$619K Hold
5,646
– – 0.02% 286
2022
Q2 		$746K Buy
5,646
+3,028
+116% +$397K 0.02% 267
2022
Q1 		$347K Buy
2,618
+334
+15% +$40.1K 0.01% 391
2021
Q4 		$266K Sell
2,284
-155
-6% -$18.2K 0.01% 403
2021
Q3 		$293K Buy
+2,439
New +$284K 0.01% 363

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bradley Foster & Sargent's AZN Position: Q2 2026 in Review

Bradley Foster & Sargent increased its AstraZeneca (AZN) stake by 6.4% in Q2 2026, buying an estimated $43.4K and bringing the position to 3,851 shares worth $730K. The position accounts for 0.01% of the portfolio, ranked #348.

Bradley Foster & Sargent first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.2M in Q3 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bradley Foster & Sargent held 3,851 shares of AstraZeneca worth $730K as of Q2 2026.
  • Bradley Foster & Sargent bought 231 AstraZeneca shares in Q2 2026, an estimated $43.4K.
  • AstraZeneca made up 0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #348 holding.
  • Bradley Foster & Sargent first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
  • Bradley Foster & Sargent's AstraZeneca position peaked at $3.2M in Q3 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.